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16S rRNAAbstract The present study aimed to establish a genus-speciﬁc PCR-based assay to detect heli-
cobacters using 16S rRNA gene as the target template. We designed the hemi-nested primers based
on sequences of 16S rRNA gene of 34 types of Helicobacter species. The inclusivity, sensitivity, and
speciﬁcity of the PCR assay using these primers were examined in three different models, compris-
ing feces simulated samples, BLAB/c mice infection model and clinic patients samples. The detec-
tion sensitivity of Helicobacter pylori, Helicobacter hepaticus and Helicobacter bilis strains from
feces simulated samples was all 102 CFU/ml. We successfully detected H. hepaticus and H. bilis
in the liver, cecum and feces of experimentally infected mice. H. pylori was successfully detected
in the feces samples from 3 patients infected with H. pylori while not in the feces samples from 3
healthy human. However, the C97/C05–C97/C98 PCR assay detected H. pylori in the 2 positive
samples. Due to the PCR assay’s excellent inclusivity, high sensitivity and speciﬁcity it may be used
to detect the presence of Helicobacters.
 2015 Production and Hosting by Elsevier B.V. on behalf of King Saud University. This is an open access
article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
A large number of studies conﬁrmed that Helicobacter spp.
have their share in the pathogenesis of diseases of the digestive
system, ever sinceHelicobacter pylori was ﬁrst recognized as an
important factor in the genesis of gastritis, peptic ulcer and
gastric adenocarcinoma in human (Parsonnet et al., 1991;
Dunn et al., 1997). The number of Helicobacter spp. identiﬁed
is increasing as more research is done in this ﬁeld. With 34
Helicobacter species now formally named according to LPSN
(http://www.bacterio.net/h/helicobacter.html), it is clear that
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hosts, as well as colonize different anatomical regions of the
gastrointestinal system (Fox, 2002; Recordati et al., 2009).
Culture of helicobacter organisms can be used to identify
infected hosts. However, the bacteria are fastidious and initial
in vitro isolation therefore requires special microaerophilic
conditions and 5–7 days (Fox et al., 1994, 1995). Detection
of helicobacters by culture is further complicated by the pres-
ence of normal ﬂora, since the preferred site for isolation of
the bacteria is the gastrointestinal tract. In addition to culture,
the immunological assays are also important techniques. How-
ever, the difﬁculties to culture many fastidious Helicobacter
species to obtain enough cells for the extraction of cell surface
proteins are still a challenge. Therefore there is a need to
develop an easy to use and reliable assay to detect and discrim-
inate helicobacters (Wadstrom et al., 2009).
The association between the Helicobacter spp. and gas-
trointestinal diseases can also be determined by proving the
presence of theHelicobacter spp. DNA in samples that are col-
lected during the examinations. The procedure became simpler
and more precise, which allowed an evolution of PCR in the
sense of being more feasible, but also a sophisticated and reli-
able method that has proven its usefulness in dealing with the
association. (Engstrand et al., 1992; Lin et al., 1995; Fox et al.,
1998; Myung et al., 2000; Monstein et al., 2002). However,
Poynter et al. reported that three out of six different commer-
cial laboratories performing helicobacter testing on the same
spiked fecal samples failed to detect and identify Helicobacter
hepaticus due to the differences in the design of their PCR
assays (Poynter et al., 2009). Bulajic et al. concluded that fur-
ther investigation of Helicobacter spp. role in the development
of malignancies and other diseases requires targeting of new
genome sequences or design of more speciﬁc primers (Bulajic
et al., 2012). The PCR subtypes used included nested PCR
and single-round PCR. Nested PCR has been used frequently
in recent years due to its higher speciﬁcity. The most sensitive
and widely used method for detecting helicobacter infections is
PCR targeting at a genus-speciﬁc and conserved region of 16S
rRNA (Battles et al., 1995; Bulajic et al., 2012). In this study,
we have tried to establish and optimize a hemi-nested PCR
assay that would simultaneously detect and differentiate 34
of the formally named helicobacters from feces samples. The
primers were designed based on the sequences of 16S rRNA.
2. Materials and methods
2.1. Strains and culture
H. pylori (ATCC43504), H. hepaticus (ATCC51448), Heli-
cobacter bilis (ATCC43879) were obtained from the depart-
ment of Gastroenterology in NanFang Hospital. H. pylori
were cultured on Brucella agar. H. hepaticus, H. bilis and
Campylobacter jejuni were cultured on selective C. jejuni agar
(containing 10 mg/L vancomycin, 5 mg/L trimethoprim, and
2500 U/L polymyxin B), supplemented with 5–10% sterile
deﬁbrinated sheep blood. Plates were incubated for 3–7 days
under microaerobic conditions at 37 C at high humidity in
microaerobic chamber (10%CO2, 5%O2, and 85%N2). Escher-
ichia coli, and Enterococcus faecalis were cultured in Columbia
agar at 37 C.2.2. Genomic DNA extraction
Bacteria were cultured on plates and the cells were harvested
and washed twice with 1 ml of PBS. Bacteria genomic
DNA extraction was performed using Qiagen RNA/DNA
Mini Kit (Qiagen Inc.) according to the manufacturer’s
instructions.
2.3. DNA extraction from feces and tissue
DNA was extracted from 220 mg of fecal and tissue specimen
using the QIAamp DNA Mini stool Kit (Qiagen Inc.) accord-
ing to the manufacturer’s instructions. DNA content and pur-
ity were determined spectrophotometrically by measuring the
A260/A280 optical density ratio.
2.4. The primers were analyzed using DNAMAN 8.0 and
OLIGOU 7.0
2.4.1. PCR amplification
The hemi-nested universal Primers were designed with Primer
Premier 6.0 on the basis of nucleotide sequence of 16S rRNA
of all 34 type strains. Primary reactions used 1.0 ll of puriﬁed
bacteria DNA (1 ng), or 5.0 ll of serially diluted suspensions
of bacteria spiked stool DNA (25–100 ng) as the template in
a total volume of 50 ll, unless otherwise stated. In the ﬁrst
ampliﬁcation step Genomic DNA was ampliﬁed in a total vol-
ume of 50 ll containing PCR buffer (1X), 200 lM dNTP,
1.5 mMMg2+, 0.2 mM primers (outer-F: 50 CTGGCGGCG-
TGCCTAATAC 30 and outer-R: 50 CTCACGACACGAGCT
GAC 30) and 1.5 U Taq DNA polymerase (TaKaRa, Japan).
The reaction mixture was initially denatured for 3 min at
94 C, then ampliﬁed for 30 cycles as follows: denaturation
for 30 s at 94 C, primer annealing for 30 s at 58 C and exten-
sion for 30 s at 72 C. A ﬁnal extension step was done for
5 min at 72 C (Thermocycler ABI 9700). An ampliﬁcation
product of 1000 bp by the outer primers was expected. In the
second ampliﬁcation step PCR was repeated as above with
minor alterations: 1.0 ll of amplicon (the ﬁrst step PCR prod-
ucts diluted 100-fold) was used for the second ampliﬁcation
step, primer annealing for 50 s at 58 C, and inner-F (50
CTGGCG GCGTGCCTAA TAC 30)/inner-R (50 ACCCTC-
TCAGGCC GGATACC 30) primers were used. The expected
size of the amplicon was 250 bp or 430 bp. PCR product
sequencing was performed by BGI Corporation with heli-
cobacter (inner-F and inner-R) sequencing primers (Table 1).
The sequences were determined by means of an automatic
sequencer (3730XL; Applied Biosystems), the dye terminator
reaction (Bigdye V3.1 Mix kit). For quality control, each
DNA extraction and PCR ampliﬁcation run included a posi-
tive control and negative control (double distilled water
instead of sample). All PCR assays were performed in tripli-
cate on three separate occasions.
2.5. Assay specificity
The speciﬁcity of the primers was tested under the above-
mentioned conditions as well as with DNAs extracted from
C. jejuni, E. coli, and E. faecalis.
Table 1 Comparison of the hemi-nested primers used in this study and other universal primers.
References Sequence Inclusivea Evaluationb
Avenaud et al.
(2000)
Forward HS1: 50
AACGATGAAGCTTCTAGCTTGCTAG 30
8 30-end dimer between the primers
Reverse HS2: 50
GTGCTTATTCGTTAGATACCGTCAT 30
Coppola et al.
(2002)
Forward 50 ACGATGAAGCTTCTAGCTTGCTAG 30 9 30-end Forward Primer dimer
Reverse 50 TGCTTATTCGTTAGATACCGTCAT 30
Huang et al.
(2004)
Forward 50 GTCATGACGGGTATCC 30 21 High diﬀerence between (F/R) product and primer
melting temperaturesReverse 50 ACTTCACCCCAGTCGCTG 30
Fukuda et al.
(2002)
Forward 50 GCTATGACGGGTATCC 30 30 High diﬀerence between (F/R) product and primer
melting temperaturesReverse 50 GATTTTACCCCTACACCA 30
Nilsson et al.
(2006)
Outer
forward
50 CTATGACGGGTATCCGGC 30 31 High diﬀerence between (F/R) product and primer
melting temperatures
High diﬀerence between (U/L) product and oligo
melting temperatures
Terminal stability of the Forward Primer is too high
Terminal stability of the Upper Oligo is too high
Outer
reverse
50 CTCACGACACGAGCTGAC 30
Inner
forward
50 CTATGACGGGTATCCGGC 30
Inner
reverse
50 TCGCCTTCGCAATGAGTATT 30
Bohr et al.
(2004)
Forward 5_-GCTATGACGGGTATCC-3_ 31 High diﬀerence between (F/R) product and primer
melting temperaturesReverse 5_-TCGCAATGAGTATTCCTCTT-3
Rocha et al.
(2005a)
Forward C96: 50 ACGGGTGAGTAACGCATAGG 30 10 High diﬀerence between (F/R) product and primer
melting temperaturesReverse R4-16SCHPEC: 50 CCTACGGTTACCTT
GTT ACGAC 30
Fox et al. (1998) Outer
forward
C97: 50 GCTATGACGGGTATCC30 25 High diﬀerence between (F/R) product and primer
melting temperatures
Outer
reverse
C05: 50 ACTTCACCCCAGTCGCTG 30
Inner
forward
C97: 50 GCTATGACGGGTATCC 30
Inner
reverse
C98: 50 GATTTTACCCCTACACCA 30
Pellicano et al.
(2004)
Outer
forward
50 ATTAGTGGCGCACGGGTGAGTAA 30 6 High diﬀerence between (F/R) product and primer
melting temperatures
High diﬀerence between (U/L) product and oligo
melting temperatures
30-end dimer between the Forward and Reverse primers
30-end dimer between the Upper and Lower oligos
Outer
reverse
50 TTTAGCATCCCGACTTAAGGC 30
Inner
forward
50 GAACCTTACCTAGGCTTGACATTG 30
Inner
reverse
50 GGTGAGTACAAGACCCGGGAA 30
Goto et al.
(2000)
Forward 50 CTA TGACGG GTA TCC GGC 30 31 High diﬀerence between (F/R) product and primer
melting temperatures
Terminal stability of the Forward Primer is too high
Reverse 50 CTC ACGACA CGA GCT GAC 30
Riley et al.
(1996)
Forward H276f: 50 CTATGACGGGTATCCGGC 30 29 Terminal stability of the Upper Primer is too high
Excessive diﬀerence between product and primer
melting temperatures
Reverse H676: 50 ATTCCACCTACCTCTCCCA 30
This study Outer
forward
50 CTGGCGGCGTGCCTAATAC 30 34 None
Outer
reverse
50 CTCACGACACGAGCTGAC 30
Inner
forward
50 CTGGCGGCGTGCCTAATAC 30
Inner
reverse
50 ACCCTCTCAGGCCGGATACC 30
a Numbers in the fourth column indicate the number of helicobacters totally matched with the primer.
b The primers were analyzed by OLIGOU7.0 on the basis of H. pylori 16S rRNA.
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To investigate the sensitivity of the primers in the setting of
abundant genomic DNA of enteric bacteria, the nested PCR
was performed using DNA extracted from fecal samples of a
healthy human uninfected with H. pylori, H. hepaticus and
H. bilis. The fecal samples were spiked with serially diluted sus-
pensions of H. pylori, H. hepaticus and H. bilis. In some exper-
iments, 10-fold dilutions (10, 102, 103, 104, 105, and, 106 CFU)
of a known stock concentration of three helicobacters sus-
pended in PBS were spiked into 200 mg fecal samples before
DNA extraction.
2.7. Animal infection model and sample collection
Speciﬁc pathogen-free BLAB/c mice were purchased at 6 –
7 weeks of age from Nanfang University. To determine
whether BLAB/c mice were free of H. hepaticus and H. bilis
or not, we used our assay and conventional method (Fox
et al., 1998; Rocha et al., 2005a). For mouse inoculation, H.
hepaticus and H. bilis were adjusted to 107–9 CFU/200 ll.
Three mice were infected with 200 ll of one of the cultures
by intragastric gavage. Once infection was established (1 and
6 weeks after inoculation), and conﬁrmed by fecal PCR, the
mice were sacriﬁced. Feces, liver and cecum samples were col-
lected to evaluate the nested-PCR assay (Jeong et al., 2011).
All procedures were approved by the Institute Animal Care
and Use Committee of Nanfang Medical University.
2.8. Ethical compliance
The procedure for obtaining specimens from humans in this
study complied with those recommended by the Regional Eth-
ical Committee on Human Experimentation of Liuzhou Peo-
ple’s Hospital. Written informed consent was obtained from
each subject.
2.9. Patient
A healthy human was considered to be uninfected by H. pylori
if no H. pylori was detected in the immunochemical staining
followed by gastroscopic biopsy specimens and rapid urease
test was negative. To determine whether healthy human were
free of H. hepaticus and H. bilis or not, we used our assay
and conventional method. This study included 5 patients with
H. pylori infection and 5 healthy human without H. pylori
infection. The feces samples from 5 patients with H. pylori
infection and 5 healthy human regularly examined in a hospi-
tal in Liuzhou City were collected in September 2014. Samples
were kept on ice during transfer to the Department of Micro-
biology, Liuzhou People’s Hospital, and were tested as soon as
possible. Neither patient nor healthy human has used follow-
ing medications: H2 histamine blockers, antimicrobials, pro-
ton pump inhibitors and bismuth salts within the previous
four weeks before samples were collected.
3. Results
The nested PCR primers were designed to the target 16S
rRNA gene speciﬁc to all 34 type strains of Helicobacterspp., not including any rare bases. Theoretically, the primers,
being able to detect all the type strains, have not any faults
according to the Oligo7.0 Software evaluation. In comparison
with it, not only the inclusivity but also some faults lies in
other primers usually used in the literature, as described in
Table 1. Furthermore, the expected products size and optimal
annealing temperature to 34 type strains were described in
Table 2. Numbers in the sixth column indicate the positions
of the primers to different type strains. The optimal annealing
temperature ﬂuctuates from 55.3 C to 57.8 C for the inner
primers, and from 56.5 C to 57.9 C for the outer primers
(Table 2). In practice, the excellent validity of the method
was examined by feces simulated samples (Fig. 2), BLAB/c
mice infection models (Fig. 3) and H. pylori infection fecal
samples (Fig. 4).
DNAs extracted from H. pylori, H. hepaticus and H. bilis
gave, respectively, a single ampliﬁcation product of 997 bp,
990 bp and 1172 bp after the ﬁrst-round PCR (Fig. 1).
Speciﬁcity of the genus-speciﬁc primer set was determined
by amplifying DNAs prepared from the control strains. The
expected DNA fragment was ampliﬁed from DNAs from the
Helicobacter spp. tested (Fig. 2). Template DNAs from other
bacterial genera commonly found in the human intestine were
also evaluated for PCR ampliﬁcation with the Helicobacter
genus-speciﬁc primers. A product of the expected size was
not observed with DNA from E. coli, C. jejuni, E. faecalis, Bac-
teroides fragilis, Pseudomonas aeruginosa, Staphylococcus aur-
eus and negative control.
The clinical detection limits determined by spiking knowing
amount of H. pylori, H. hepaticus and H. bilis into healthy
human fecal sample, were all 10 CFU/100 ll (Fig. 3), as previ-
ously described (Moyaert et al., 2008).
Nested PCR analysis was performed on liver, cecum and
feces samples obtained from infected mice after intragastric
administration of H. hepaticus and H. bilis. Nested PCR using
DNA extracted from the feces of three mice before H. hepati-
cus infection produced no ampliﬁcation signal whereas single
ampliﬁcation signal was observed using DNA extracted after
H. hepaticus infection (Fig. 4A). DNA from liver and cecum
samples from 3 H. hepaticus infection mice showed the 233-
bp product except for one mouse’ liver sample (Fig. 4B).
DNA from feces samples collected before H. bilis infection
did not show the 413-bp product with the nested PCR whereas
the 413-bp product was observed after infection (Fig. 4C).
DNA from liver and cecum samples from H. bilis infected mice
all showed speciﬁc ampliﬁcation with the nested PCR except
for two liver samples (Fig. 4D).
4. Discussion
DNAs extracted from three feces samples from patients
infected with H. pylori gave a single ampliﬁcation product
after our PCR but DNAs from two positive samples gave a
single ampliﬁcation product after C97/C05–C97/C98 PCR.
Our PCR produced no ampliﬁcation when DNAs obtained
from feces samples of healthy human were used as template.
Both C97/C98 PCR and C97/C05 PCR can’t detect H. pylori
in the positive fecal samples (Fig. 5B).
Molecular diagnostic methods using the polymerase chain
reaction (PCR) are the gold standard in Helicobacter diagnos-
tics. Most methods rely on the ampliﬁcation of a section of the
Table 2 The location and optimal annealing temperature of the primers in 34 type strains of Helicobacter spp.a
Taxon Type strain 16S rRNA
accession NO.
Location Optimal annealing
temperatureb (C)
Helicobacter acinonychis H. strain 90-119/ATCC51101 M88148 36/270/1031 57.5/57.1
Helicobacter anseris H. strain MIT 04-9362/ATCC BAA-1299 DQ415545 28/261/1020 57.5/57.4
Helicobacter aurati H. strain MIT 97-5075c/ATCC BAA-1 AF297868 28/261-1017 56.7/57.6
Helicobacter baculiformis H. strain M50 /CCUG 53816/LMG 23839 EF070342 28/259/1010 57.1/57.9
Helicobacter bilis H. strain Hb1/ATCC 51630 U18766 28/441/1199 56.5/57.2
Helicobacter bizzozeronii H. strain Ha¨nninen 1/Storkis/CCUG 35545 Y09404 9/240/1000 56.9/57.8
Helicobacter brantae H. strain MIT 04-9366/ATCC BAA-1298 DQ415546 28/263/1021 57.4/57.7
Helicobacter canadensis H. strain NLEP-16143/ATCC 700968 AF262037 13/246/1003 57.3/57.3
Helicobacter canis H. strain ATCC 51401 AY631945 28/261/1020 57.2/57.6
Helicobacter cetorum H. strain MIT 99-5656/ATCC BAA-540 AF292378 28/262/1023 56.9/57.6
Helicobacter cholecystus H. strain Hkb-1/ATCC 700242 AY686606 28/261/1019 57.5/57.9
Helicobacter cinaedi H. strain Fennell 165/CCUG 18818 M88150 28/262/1020 57.4/57.7
Helicobacter cynogastricus H. strain JKM4/LMG 23188 DQ004689 28/259/1024 57.0/57.7
Helicobacter equorum H. strain EqF1/CCUG 52199 DQ307735 26/259/1017 57.2/57.7
Helicobacter felis H. strain CS1/ATCC 49179 M57398 28/259/1020 57.2/57.8
Helicobacter fennelliae H. strain Fennell 231/ATCC 35684 M88154 36/622/1038 55.3/56.5
Helicobacter ganmani H. strain CMRI H02/CCUG 43526/CIP 106846 AF000221 9/240/998 56.8/57.4
Helicobacter heilmannii Strain ASB1 = DSM 24751 HM625820 36/267/1028 57.0/57.8
Helicobacter hepaticus H. strain Hh-2/ATCC 51448 U07574 28/261/1017 57.3/57.7
Helicobacter macacae MIT 99-5501 = LMG 26486 AF333338 72/470/1227 56.0/56.9
Helicobacter marmotae H. strain MIT 98-6070/ATCC BAA-546 AF333341 28/261/1018 57.2/57.5
Helicobacter mastomyrinus H. strain MIT 97-5574/ATCC BAA-1046 AY742307 28/550/1307 56.2/57.0
Helicobacter mesocricetorum H. strain MU 97-1514/ATCC 700932 AF072471 12/245/1003 56.7/57.3
Helicobacter muridarum H. strain ST1/ATCC 49282 M80205 33/266/1024 57.3/57.6
Helicobacter mustelae H. strain R85-13-6/ATCC 43772 M35048 36/269/1028 57.8/57.6
Helicobacter nemestrinae H. strain T81213-NTB/ATCC 49396 X67854 36/266/1027 56.8/56.7
Helicobacter pametensis H. strain Seymour B9/ATCC 51478 M88147 35/270/1028 57.5/57.7
Helicobacter pullorum H. strain ATCC 51801/CCUG 33837 AY631956 29/262/1020 57.6/57.8
Helicobacter pylori H. strain Royal Perth Hospital 13487/ATCC 43504 U01330 36/271/1032 57.1/57.6
Helicobacter rodentium H. strain MIT 95-1707/ATCC 700285 U96296 13/244/1002 57.2/57.6
Helicobacter salomonis H. strain Inkinen/CCUG 37845/CIP 105607 U89351 13/244/1005 57.1/57.8
Helicobacter suis H. strain HS1/DSM 19735 EF204589 18/249/1010 56.5/57.7
Helicobacter trogontum H. strain LRB 8581/ATCC 700114 U65103 13/246/1002 57.5/57.8
Helicobacter typhlonius H. strain MIT 97-6810/ATCC BAA-367 AF127912 13/405/1161 55.8/57.1
a The location and optimal annealing temperature for the hemi-nested primers were determined by OLIGOU7.0.
b The former temperature is for the inner primers, and the latter is for outer primers.
Figure 1 First PCR ampliﬁcation of the 16S rRNA gene of H.
pylori, H. hepaticus and H. bilis. LaneM, markers (Omega Marker
DL-2000); NC, negative control; lane 1, H. pylori; lane 2, H.
hepaticus; lane 3, H. bilis.
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depend heavily on the PCR design and the time of its publica-
tion because new sequences are continually being submitted toFigure 2 Ethidium bromide-stained agarose gel showing products res
markers (Omega Marker DL-2000); lane 1, H. pylori; lane 2, H. hepa
faecalis; lane7, B. fragilis; lane 8, P. aeruginosa; lane 9, S. aureu;. Landatabases. Other target genes were also used as PCR target
such as cdtB, vacA, glmM, glm, cagA, rps4, and 26 kDa’s port.
Many studies in the past years have been always trying to
ﬁnd an excellent assay in inclusivity, sensitivity and speciﬁcity.
The key to breakthrough is primers design. C97/C05–C97/C98
PCR cannot detect all positive H. pylori samples for primers
itself. Another, multiple PCR is also very important. Regular
PCR is difﬁcult to detect helicobacter in fecal samples. Multi-
ple PCR is more effective than regular PCR. In this report, we
describe a hemi-nested PCR assay, which has excellent primers
designed without any faults, for the detection of all species of
helicobacter organisms formally named by LPSN. Actually,
more faults lie in the primers designed for multiple PCR. Inulting from ampliﬁcation of DNA from various bacteria. LaneM,
ticus; lane 3, H. bilis; lane 4, E. coli; lane 5, C. jejuni; lane 6, E.
e 10, negative control.
Figure 4 Nested PCR with experimental samples collected from H. hepaticus infected mice (A and B). Nested PCR ampliﬁcation of
DNA extracted from feces samples from 3 uninfected control (lane 1–3 in A) and 3 infected mice (lane 4–6 in A). Nested PCR
ampliﬁcation of DNA extracted from liver (lane 1–3 in B) and cecum samples (lane 4–6 in B) from 3 infected mice. Nested PCR with
experimental samples collected from H. bilis infected mice (C and D). Nested PCR ampliﬁcation of DNA extracted from feces samples
from 3 uninfected control (lane 1–3 in C) and 3 infected mice (lane 4–6 in C). Nested PCR ampliﬁcation of DNA extracted from liver (lane
1–3 in D) and cecum samples (lane 4–6 in D) from 3 infected mice. LaneM, markers (Omega Marker DL-2000); PC, positive control; NC,
negative control.
Figure 3 Sensitivity of detection of H. pylori (A), H. hepaticus (B) and H. bilis (C)-speciﬁc 16S rRNA gene by the nested PCR. Tenfold
dilutions of pure bacterial culture were spiked into healthy human stool, and nested PCR was performed by using the extracted DNA from
contaminate stool. LaneM, markers (Omega Marker DL-2000); PC, positive control; NC, negative control; lane 1, 106 CFU; lane 2,
105 CFU; lane 3, 104 CFU; lane 4, 103 CFU; lane 5, 102 CFU; lane 6, 10 CFU; lane 7, 1 CFU.
270 H. Qin et al.view of it, our primers are more valuable. Besides, inspection
of the 16S rRNA gene sequences from all 34 type strains
revealed a 100% match with our Helicobacter genus-speciﬁc
oligonucleotide primers. Thus, in retrospect, successful ampli-
ﬁcation of DNA from all helicobacter species DNA with these
primers is expected.It is known that PCR assays that function very speciﬁcally
by using speciﬁc DNA samples as the template may not work
properly when more complex DNA samples are studied (Bohr
et al., 2002). We suspected that any fault of primers designed,
even a base mismatch, may be ampliﬁed in the complex DNA
samples. HS1/HS2 assay can detect more than 8 types of
Figure 5 Nested PCR ampliﬁcation of DNA extracted from feces samples from patients infected with H. pylori and uninfected control.
(A) Left, gastric membrane from H. pylori infection patient. Right, gastric membrane from H. pylori non-infection patient (200x,
Immunohistochemical staining). (B) LaneM, markers (Omega Marker DL-2000); lane 1–3, positive samples PCR using our primers; lane
4–6, positive samples PCR using C97/C05–C97/C98 primers; lane 7–9, negative samples PCR using our primers; lane 10–12, positive
samples PCR using C97/C98 primers; lane 13–15, positive samples PCR using C97/C05 primers.
Diagnosis of Genus Helicobacter 271helicobacters using the puriﬁed DNA extracts as the template
though it cannot totally match helicobacters 16S rRNA.
Where applicable, the assay performed suboptimally on inclu-
sivity. The investigators chose to include DNA extracts from
other bacteria commonly found in the gastric and/or intestinal
ﬂora to evaluate the speciﬁcity of their assays. Moyaert et al.
showed difﬁculties to accurately discriminate closely related
taxa (Moyaert et al., 2008). Therefore, in our study, additional
DNA extracts from feces of human uninfected with H. pylori,
H. hepaticus and H. bilis were used to test assay speciﬁcity. No
non-speciﬁc ampliﬁcation was found. The assay sensitivity
reached 10 bacterial cells per reaction mixture. The capability
of the PCR assay was further tested by detection of H. hepati-
cus and H. bilis from samples obtained from infected mice,
including liver, cecum and feces. Both bacteria were success-
fully identiﬁed. Moreover, we also evaluated the capability
of the PCR assay by testing feces from patients infected with
H. pylori. H. pylori was successfully identiﬁed in the feces of
all infected patients. In this study, we found H. pylori test in
fecal samples is more difﬁcult than H. hepaticus and H. bilis.
We guessed that fecal test is more sensitive for enterohepatic
helicobacters than gastric helicobacters for the colonized loca-
tion. Enterohepatic helicobacters DNA in fecal sample is more
than gastric helicobacters. It was found that frozen fecal sam-
ple from H. pylori infection patients is apt to false negative
results. We found that the H. pylori DNA in process of thaw-
ing may be partly destroyed. For more accurate results, we use
the fresh fecal samples when testing H. pylori.
5. Conclusion
In our study, it was demonstrated that the hemi-nested PCR
assay is highly reliable and sensitive for the genus-level identi-
ﬁcation of Helicobacter spp. This assay is able to detect all thecurrently known species of helicobacter and identify different
species of helicobacter. Therefore, it can serve as a powerful
tool for the diagnosis of the helicobacter infections.Acknowledgment
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